Diagnosing and Treating Low Blood Sugar Levels
Diagnosing and Treating Low Blood Sugar Levels
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), September 2008
Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001276
Purpose
Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia.
Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.
Condition
Hypoglycemia
Insulinoma
MedlinePlus related topics: Hypoglycemia
U.S. FDA Resources
Study Type: Observational
Official Title: Fasting Hypoglycemia: Diagnosis and Treatment
Further study details as provided by National Institutes of Health Clinical Center (CC):
Study Start Date: January 1991
Detailed Description:
The purpose of this protocol is to continue our studies of the evaluation and treatment of patients with fasting hypoglycemia due to diverse etiologies. Patients will be admitted to the Clinical Research Center under this protocol and undergo supervised fasting, dynamic tests of insulin secretion when appropriate, medically indicated imaging studies, and appropriate medical and surgical treatment.
Eligibility
Ages Eligible for Study: 10 Years and older
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Criteria
INCLUSION CRITERIA
Documentation of plasma glucose below 45 mg/dl is required for enrollment.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001276
Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010
Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
More Information
NIH Clinical Center Detailed Web Page
Publications:
Bar RS, Gorden P, Roth J, Siebert CW. Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. J Clin Endocrinol Metab. 1977 Jun;44(6):1210-3.
Blackshear PJ, Rotner HE, Kriauciunas KA, Kahn CR. Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. Ann Intern Med. 1983 Aug;99(2):182-4.
Comi RJ, Gorden P. Approach to hypoglycemia in adults. Compr Ther. 1987 Mar;13(3):38-44. No abstract available.
Study ID Numbers: 910066, 91-DK-0066
First Received: November 3, 1999
Last Updated: October 22, 2008
ClinicalTrials.gov Identifier: NCT00001276
Health Authority: United States: Federal Government
